Quantitative Understanding of QTc Prolongation and Gender as Risk Factors for Torsade de Pointes.

Clin Pharmacol Ther

Division of Pharmacometrics, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.

Published: February 2018

Several risk factors for development of a potentially fatal ventricular arrhythmia, torsade de pointes, have been observed, including female gender. However, in most investigations, only few torsade events were included and/or rarely were postdose heart rate corrected QT (QTc) measurements included, as a surrogate of drug exposure. We developed a multivariate logistic regression model using data from 22,214 patients (33% women) with 84 torsade events (56% women) to evaluate the relationship between risk factors for torsade using data from four anti-arrhythmic drug development programs. Before model development, we evaluated different QT/QTc postdose metrics (average, maximum, etc.) to determine which QT metric should be included into the model. The developed multivariate model showed that, after accounting for known risk factors for torsade and postdose QTc, that female gender remained a significant risk factor for torsade.

Download full-text PDF

Source
http://dx.doi.org/10.1002/cpt.783DOI Listing

Publication Analysis

Top Keywords

risk factors
16
factors torsade
12
torsade pointes
8
female gender
8
torsade events
8
developed multivariate
8
torsade
7
risk
5
quantitative understanding
4
understanding qtc
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!